November 8, 2026StocksTechnology·Bearish·clinical trial
CABA discloses third ICANS case in RESET-MYOSITIS trial
CABA's new press release and corporate presentation disclose a third ICANS case, Grade 1 (the mildest grade), occurring for the first time in the RESET-MYOSITIS trial.
Detected & updated continuously · Source: Nebula
Story subjects
CABA